Eleusis SPAC slide image

Eleusis SPAC

Leadership Team Deep Expertise Spanning Discovery, Development, and Delivery; 992 Peer-Reviewed Publications¹ SHLOMI RAZ Chief Executive Officer Goldman Sachs J.P. Morgan David Nichols, PhD Director, Molecular Pharmacology Discovery and Preclinical Yong Ren, PhD Director, Discovery Research Charles Nichols, PhD Scientific Founder & Sponsored Researcher Graham Johnson, PhD Director, Medicinal Chemistry PURDUE UNIVERSITY LSU Health NEW ORLEANS C SAREPTA THERAPEUTICS Melinta ROB CONLEY SVP, Clinical Development Lilly Bristol-Myers Squibb UNIVERSITY of MARYLAND SCHOOL OF MEDICINE Allan Shepard, PhD Director Translational Research Tim Foster, PhD Sponsored Researcher Pfizer Lundbeck رار NOVARTIS LSU Health NEW ORLEANS eleusis 1) Statistics are cumulative across all six professionals listed herein. KATHY KALUHIOKALANI President, Andala OPTUM® UPMC LIFE CHANGING MEDICINE Yoni Weiss, MD VP, Clinical Development Sarah Blondell, MSc VP, Clinical Operations Tim Williams, MD Director, Clinical Development Clinical teva Regenera QUINTILES TMC PHARMA DAVID WEINER, MD VP, Drug Discovery lumos PHARMA Neiloufar Family, PhD VP, Health Solutions Rachel Handy, PhD VP, Quality Assurance NHS VP, Joanna Sambor ACADIA Pharmaceuticals Regulatory Affairs L'ECOLE HAUTES ETUDES SOCIALES Imperial College London Vantia therapeutics FERRING PHARMACEUTICALS abbvie Takeda GENE RAMIREZ Chief Financial Officer BTIG Robertson Stephens Commercial Berrak Kocaoglu, MSc VP, Commercial Strategy imshealth™ INTELLIGENCE APPLIED. Jessica Joffe Stein VP, Marketing & Communications Alex Speiser Director, Corporate Development Davita. ORTHOGONAL 7
View entire presentation